PNTG - The Pennant Group,... Stock Analysis | Stock Taper
Logo
The Pennant Group, Inc.

PNTG

The Pennant Group, Inc. NASDAQ
$33.71 10.56% (+3.22)

Market Cap $1.17 B
52w High $35.00
52w Low $21.18
P/E 44.95
Volume 526.00K
Outstanding Shares 34.59M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $289.32M $19.34M $8.64M 2.99% $0.25 $19.88M
Q3-2025 $229.04M $35.92M $6.08M 2.66% $0.18 $12.48M
Q2-2025 $219.5M $18.77M $7.08M 3.23% $0.21 $14.01M
Q1-2025 $209.84M $16.73M $7.78M 3.71% $0.23 $14.47M
Q4-2024 $188.89M $15.77M $5.76M 3.05% $0.17 $11.08M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $17.02M $968.18M $593.93M $332.6M
Q3-2025 $2.34M $753.64M $410.6M $321.91M
Q2-2025 $14.38M $751.42M $417.79M $313.3M
Q1-2025 $5.22M $743.62M $420.6M $303.6M
Q4-2024 $24.25M $679.52M $367.56M $293.28M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $25.02M $20.96M $-153.02M $146.75M $14.69M $13.97M
Q3-2025 $6.08M $13.92M $-14.6M $-11.38M $-12.05M $10.47M
Q2-2025 $7.98M $34.64M $-10.05M $-15.43M $9.16M $31.58M
Q1-2025 $7.78M $-21.23M $-50.3M $52.51M $-19.02M $-23.19M
Q4-2024 $6.53M $20.57M $-4.4M $3.61M $19.78M $17.25M

Revenue by Products

Product Q1-2025Q2-2025Q3-2025Q4-2025
Home Health And Hospice Services Segment
Home Health And Hospice Services Segment
$160.00M $170.00M $170.00M $230.00M
Senior Living Services Segment
Senior Living Services Segment
$50.00M $50.00M $60.00M $60.00M

Q4 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at The Pennant Group, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Pennant shows a combination of solid current profitability, strong cash generation, and a distinctive operating model. The company runs its overhead leanly, converts earnings into cash effectively, and has built a sizable asset and equity base over time. Its decentralized structure, cultural focus, and investment in data and analytics provide a clear strategic identity in the home health, hospice, and senior living space. Leadership development, proven acquisition capabilities, and growing partnerships with health systems and technology providers further support its ability to scale.

! Risks

The main concerns center on financial leverage, thin margins, and execution demands. High debt relative to equity and assets, together with only modest liquidity, leaves the business more vulnerable to shocks in reimbursement, labor costs, or referral volumes. Profit margins are positive but not generous, limiting the buffer for error in a heavily regulated and labor-intensive industry. An aggressive acquisition strategy, combined with substantial intangible assets, adds integration and impairment risk. Finally, innovation is mostly operational rather than patent-protected, so sustained advantage depends on consistent execution and cultural strength rather than exclusive technology.

Outlook

The overall picture is of a company with a credible, differentiated model and healthy current performance, but one that is operating with a relatively tight financial and operational margin for error. If Pennant continues to execute well on acquisitions, maintains its culture, and leverages its technology partnerships and analytics to improve outcomes and efficiency, it is positioned to benefit from long-term trends such as population aging and the shift toward care in lower-cost settings. However, its elevated leverage and modest liquidity mean that careful balance sheet management and disciplined capital allocation will be critical, especially in the face of regulatory changes or economic slowdowns. With only one year of detailed financial data, confidence in long-term trends should remain cautious and focused on how these strategic themes play out over time.